Drug & intervention
triptorelin pamoate
RxCUI 338529
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Clinical trials
5 shownRadiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RPNCT03899077 · 2019-04-05
UNKNOWNHigh-Dose Brachytherapy in Treating Patients With Prostate CancerNCT02346253 · 2015-01-13
COMPLETEDSupportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate CancerNCT02168062 · 2014-06-16
TERMINATEDRandomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue AdministrationNCT01161563 · 2010-07-01
COMPLETEDHormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast CancerNCT00194792 · 2005-08-01
TERMINATEDConditions being studied
Prostate Adenocarcinoma2Cancer of Prostate1Estrogen Receptor-positive Breast Cancer1HER2-negative Breast Cancer1Progesterone Receptor-positive Breast Cancer1Prostate Cancer1Stage I Breast Cancer1Stage I Prostate Cancer1Stage II Breast Cancer1Stage IIA Prostate Cancer1Stage IIB Prostate Cancer1Stage III Prostate Cancer1Stage IIIA Breast Cancer1
Research locations
AlbanyNew York, United States1BrusselsBelgium1DallasTexas, United States1GhentBelgium1Las VegasNevada, United States1NorfolkVirginia, United States1San FranciscoCalifornia, United States1SeattleWashington, United States1ShreveportLouisiana, United States1StanfordCalifornia, United States1SyracuseNew York, United States1
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.